Skint, you are right that was exactly the point of the analysis and I agree with all you have said. What wasn't known at the time was that amyloid load is affected by many factors. Every ongoing trial in AD will fail. I hope that you are carefully invested in other AD drug companies so you avoid upcoming crashes.
Skint, you are right that was exactly the point of the analysis...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $4.125K | 824.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 58 | 64293651 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 29230739 | 21 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |